Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2.

The role of the thyroid hormone agonist 3,3',5 l-tri-iodothyronine (T3) on cholangiocytes is unknown. We evaluated the in vivo and in vitro effects of T3 on cholangiocyte proliferation of bile duct-ligated (BDL) rats. We assessed the expression of alpha(1)-, alpha(2)-, beta(1)-, and beta(2)-thyroid hormone receptors (THRs) by immunohistochemistry in liver sections from normal and BDL rats. BDL rats were treated with T3 (38.4 mug/day) or vehicle for 1 wk. We evaluated 1) biliary mass and apoptosis in liver sections and 2) proliferation in cholangiocytes. Serum-free T3 levels were measured by chemiluminescence. Purified BDL cholangiocytes were treated with 0.2% BSA or T3 (1 muM) in the absence/presence of U-73122 (PLC inhibitor) or BAPTA/AM (intracellular Ca(2+) chelator) before measurement of PCNA protein expression by immunoblots. The in vitro effects of T3 (1 muM) on 1) cAMP, IP(3), and Ca(2+) levels and 2) the phosphorylation of Src Tyr139 and Tyr530 (that, together, regulate Src activity) and ERK1/2 of BDL cholangiocytes were also evaluated. alpha(1)-, alpha(2)-, beta(1)-, and beta(2)-THRs were expressed by bile ducts of normal and BDL rats. In vivo, T3 decreased cholangiocyte proliferation of BDL rats. In vitro, T3 inhibition of PCNA protein expression was blocked by U-73122 and BAPTA/AM. Furthermore, T3 1) increased IP(3) and Ca(2+) levels and 2) decreased Src and ERK1/2 phosphorylation of BDL cholangiocytes. T3 inhibits cholangiocyte proliferation of BDL rats by PLC/IP(3)/Ca(2+)-dependent decreased phosphorylation of Src/ERK1/2. Activation of the intracellular signals triggered by T3 may modulate the excess of cholangiocyte proliferation in liver diseases.

[1]  W. Yates,et al.  A case series analysis , 2008 .

[2]  S. Glaser,et al.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. , 2007, Gastroenterology.

[3]  Á. Kenessey,et al.  Thyroid Hormone Stimulates Protein Synthesis in the Cardiomyocyte by Activating the Akt-mTOR and p70S6K Pathways* , 2006, Journal of Biological Chemistry.

[4]  S. Glaser,et al.  Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[5]  Kwang-Huei Lin,et al.  Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. , 2006, Journal of molecular endocrinology.

[6]  S. Glaser,et al.  -Dependent Cytoprotective Effects of Ursodeoxycholic and Tauroursodeoxycholic Acid on the Biliary Epithelium in a Rat Model of Cholestasis and Loss of Bile Ducts , 2006 .

[7]  D. Grandy,et al.  Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. , 2006, Journal of medicinal chemistry.

[8]  B. Fraile,et al.  Influence of thyroid hormone receptors on breast cancer cell proliferation. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  B. Kasinath,et al.  Phospholipase Cγ-Erk Axis in Vascular Endothelial Growth Factor-induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells* , 2005, Journal of Biological Chemistry.

[10]  B. Kasinath,et al.  Phospholipase Cgamma-Erk Axis in vascular endothelial growth factor-induced eukaryotic initiation factor 4E phosphorylation and protein synthesis in renal epithelial cells. , 2005, The Journal of biological chemistry.

[11]  T. Roskams,et al.  Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. , 2005, Gastroenterology.

[12]  Jianxun Lei,et al.  3,3′,5-Triiodo-l-thyronine Up-regulation of Na,K-ATPase Activity and Cell Surface Expression in Alveolar Epithelial Cells Is Src Kinase- and Phosphoinositide 3-Kinase-dependent* , 2004, Journal of Biological Chemistry.

[13]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[14]  S. Glaser,et al.  cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. , 2004, Journal of hepatology.

[15]  N. LaRusso,et al.  The Pathophysiology of Biliary Epithelia , 2004 .

[16]  A. Kalsbeek,et al.  Hyper and hypothyroidism change the expression and diurnal variation of thyroid hormone receptor isoforms in rat liver without major changes in their zonal distribution , 2004, Molecular and Cellular Endocrinology.

[17]  R. Weiss,et al.  Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. , 2004, Vitamins and hormones.

[18]  J. Bassett,et al.  Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions , 2003, Molecular and Cellular Endocrinology.

[19]  K. Takeda,et al.  Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone , 2003, Hypertension.

[20]  R. Malik,et al.  The relationship between the thyroid gland and the liver. , 2002, QJM : monthly journal of the Association of Physicians.

[21]  C. Allis,et al.  Involvement of Histone Methylation and Phosphorylation in Regulation of Transcription by Thyroid Hormone Receptor , 2002, Molecular and Cellular Biology.

[22]  S. Leoni,et al.  Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. , 2002, Endocrinology.

[23]  E. Fliers,et al.  TRβ1 Protein Is Preferentially Expressed in the Pericentral Zone of Rat Liver and Exhibits Marked Diurnal Variation. , 2002, Endocrinology.

[24]  P. Yen,et al.  Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.

[25]  S. Glaser,et al.  Regulation of cholangiocyte proliferation. , 2001, Liver.

[26]  M. Pibiri,et al.  Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  S. Glaser,et al.  Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. , 2001, Journal of hepatology.

[28]  A. Hulbert,et al.  Thyroid hormones and their effects: a new perspective , 2000, Biological reviews of the Cambridge Philosophical Society.

[29]  O. Olerup,et al.  Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[30]  D. Stevens,et al.  Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. , 2000, Endocrinology.

[31]  S. Glaser,et al.  Gastrin inhibits cholangiocyte growth in bile duct–ligated rats by interaction with cholecystokinin‐B/gastrin receptors via D ‐myo‐inositol 1,4,5‐triphosphate–, Ca2+‐, and protein kinase C α–dependent mechanisms , 2000 .

[32]  J. Sand,et al.  Association between common bile duct stones and treated hypothyroidism. , 2000, Hepato-gastroenterology.

[33]  G. M. Ledda-Columbano,et al.  Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. , 2000, Cancer research.

[34]  I. Roberts,et al.  Thyroid storm presenting with liver failure. , 1999, Journal of clinical gastroenterology.

[35]  S. Glaser,et al.  Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. , 1999, Gastroenterology.

[36]  S. Glaser,et al.  Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[37]  S. Glaser,et al.  Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver , 1999, Hepatology.

[38]  N. LaRusso,et al.  Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[39]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[40]  S. Glaser,et al.  Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. , 1996, Gastroenterology.

[41]  H. Kawakatsu,et al.  A New Monoclonal Antibody Which Selectively Recognizes the Active Form of Src Tyrosine Kinase (*) , 1996, The Journal of Biological Chemistry.

[42]  T. Ohmura,et al.  Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. , 1996, The American journal of pathology.

[43]  Y. Liaw,et al.  Clinical associations between thyroid and liver diseases , 1995, Journal of gastroenterology and hepatology.

[44]  D. Wilson.  Endocrinology of growth and growth factors. , 1995, Connective tissue research.

[45]  D. V. van Thiel,et al.  Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro , 1993, Hepatology.

[46]  J. Kao,et al.  Practical aspects of measuring [Ca2+] with fluorescent indicators. , 1994, Methods in cell biology.

[47]  G. Gores,et al.  Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. , 1992, The Journal of biological chemistry.

[48]  T. Reynolds,et al.  Hyperthyroidism and Hepatic Dysfunction: A Case Series Analysis , 1992, Journal of clinical gastroenterology.

[49]  J. Prieto,et al.  Liver changes in patients with hyperthyroidism. , 2008, Liver.

[50]  Z. Schwartz,et al.  The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone modelling of mouse long bone in vitro. , 1990, Bone.

[51]  N. LaRusso,et al.  Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. , 1989, Gastroenterology.

[52]  P. Davis,et al.  Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. , 1989, The Journal of biological chemistry.

[53]  S. Soboll,et al.  Rapid stimulation of calcium uptake into rat liver by L-tri-iodothyronine. , 1989, The Biochemical journal.

[54]  R. De vos,et al.  Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono‐ and diconjugates in the wistar rat , 1989, Hepatology.

[55]  L. Sarkozi,et al.  Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.

[56]  W. van Steenbergen,et al.  Thyroid hormones and the hepatic handling of bilirubin. II. Effects of hypothyroidism and hyperthyroidism on the apparent maximal biliary secretion of bilirubin in the Wistar rat. , 1988, Journal of hepatology.

[57]  R. R. Babb.  Associations between diseases of the thyroid and the liver. , 1984, The American journal of gastroenterology.

[58]  E. Christensen,et al.  Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. , 1980, Gastroenterology.

[59]  L. Wartofsky,et al.  Abnormalities of liver function tests in tyrotoxicosis. , 1978, Military medicine.

[60]  T. Priestman.  Recent Advances in Cytotoxic Therapy for Gastrointestinal Carcinoma: A Review 1 , 1978, Journal of the Royal Society of Medicine.

[61]  G. Doran.  Serum Enzyme Disturbances in Thyrotoxicosis and Myxoedema 1 , 1978, Journal of the Royal Society of Medicine.

[62]  R. F. Brown,et al.  Induction of deoxyribonucleic acid synthesis in the liver of the intact animal. , 1972, The Journal of biological chemistry.

[63]  A. Seligman,et al.  HISTOCHEMICAL AND ULTRASTRUCTURAL DEMONSTRATION OF γ-GLUTAMYL TRANSPEPTIDASE ACTIVITY , 1969 .

[64]  A. Seligman,et al.  Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. , 1969, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.